Aberrant expression of p53 by immunohistochemistry has been assessed differently: some authors exclusively rated p53 overexpression of tumor cells, using different cutoffs [17,19,21], whereas others included the loss of p53 as aberrant expression in their analysis [18,20]. Here, TP53 is linked to neoplasm.